Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

AnaSpec Establishes new Dedicated GMP Manufacturing Facility

Published: Monday, November 17, 2008
Last Updated: Monday, November 17, 2008
Bookmark and Share
The expansion provides an additional 5000 sq. ft. of GMP space including two class 10,000 clean rooms.

AnaSpec announces the establishment of a new facility dedicated to GMP manufacturing. Located adjacent to its current San Jose, California-based headquarters, the expansion provides an additional 5000 sq. ft. of dedicated GMP space including two class 10,000 clean rooms.

“The need for GMP-grade peptides is growing,” stated AnaSpec CEO, Dr. Frank Hong. “The expansion of our dedicated GMP manufacturing facilities will allow us to more fully address the stringent requirements of our customers.”

AnaSpec offers GMP peptides in milligram to kilogram quantities. Optimized for bulk API manufacturing, AnaSpec’s GMP peptide services offer >98% purity peptides with QC product release testing, stability studies, and full documentation for drug master files.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

AnaSpec Signs Distribution Agreement with Gene X Press
Both company’s announces non-exclusive distributor agreement that will allow Gene X Press to distribute AnaSpec’s catalog and custom products throughout Chile.
Friday, February 18, 2011
AnaSpec Showcases Premium Quality of Fluorescent Nucleic Acid Probes
Company showcases cell-impermeant and cell-permeant nucleic acid stains for detecting nucleic acids for cDNA synthesis and cloning, RNA transcription and transfection.
Wednesday, February 02, 2011
AnaSpec Introduces BAFF Protein
Naïve B-cells when treated with 20-1000 ng/ml BAFF protein shows increased IgG secretion.
Wednesday, October 06, 2010
AnaSpec Signs Distribution Agreement with Bioeasy Diagnostica
Non-exclusive distributor agreement allows Bioeasy to distribute AnaSpec’s catalog and custom products throughout Brazil.
Friday, June 18, 2010
AnaSpec Products Used in Over 400 Patents
As compiled by Google Patent Search, the number of patents citing AnaSpec’s products has passed 400.
Monday, January 25, 2010
AnaSpec to Host Bone Marrow Donor Drive
The company has partnered with AADP to host a bone marrow donor drive on its campus on February 1, 2010.
Tuesday, January 19, 2010
AnaSpec Introduces HiLyte Fluor™ 750
According to company, the new HiLyte Fluor™ 750 dye is the longest-wavelength HiLyte Fluor™ dye currently available.
Monday, January 04, 2010
AnaSpec Signs Distribution Agreement with Bioeksma UAB
The agreement allows Bioeksma UAB to distribute AnaSpec’s catalog and custom products throughout Lithuania and Latvia.
Thursday, June 04, 2009
AnaSpec Launches new Headquarters in Fremont, California
Company announces the launch of its 44,010 square foot facility to offer all top of the line lab/R&D equipment and services.
Wednesday, April 29, 2009
AnaSpec Signs Distribution Agreement with Yope Biotechnology
The non-exclusive distributor agreement allows Yope Biotechnology to distribute AnaSpec’s catalog and custom products throughout China.
Wednesday, December 03, 2008
RayBiotech and AnaSpec Sign Licensing Agreement for HiLyte™ Dyes
The licensing agreement allows RayBiotech to label antibodies with AnaSpec HiLytePlus™ and HiLyte Fluor™ dyes and integrate into protein and antibody arrays.
Tuesday, September 16, 2008
AnaSpec and Cyclex Sign Licensing Agreement for Deacetylase Activity Assay Kits
The licensing agreement allows AnaSpec to make, use, and sell deacetylase activity assay kits and the related products.
Monday, September 15, 2008
Novus Biologicals and AnaSpec Sign Licensing Agreement for HiLyte™ Dyes
The licensing agreement allows Novus to label Novus antibodies with AnaSpec HiLytePlus™ and HiLyte Fluor™ dyes.
Tuesday, July 29, 2008
AnaSpec’s Published References Passes 600
As compiled by Stanford University’s Highwire Press, the number of published papers that cite AnaSpec’s products has passed 600.
Monday, May 05, 2008
AnaSpec Introduces Longest Wavelength Assay Kit for TACE Detection
AnaSpec has introduced the SensoLyte™ 520 TACE Assay Kit, offering fluorescence detection at the wavelengths.
Thursday, August 23, 2007
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!